PDS Biotechnology proposed offering

RNS Number : 6657C
NetScientific PLC
11 February 2020
 

NetScientific plc 

("NetScientific" or the "Company")

 

PDS Biotechnology proposed offering

 

NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq:PDSB) today made a further announcement concerning its proposed offering to raise approximately US$12 million (c.£9.3 million).

 

PDS mentioned in today's announcement that, in connection with NetScientific's expression of interest to subscribe in its offering, upon consummation of the offering it will appoint a designee of NetScientific to its board of directors.

 

NertScientific is considering investing £0.5 million in the offering.

 

A further announcement will be made as soon as appropriate.

 

For more information, please contact:

  NetScientific                      Tel: 020 3514 1800

   Ian Postlethwaite, CEO and

   CFO

                                     Tel: 020 7220 1666

    WH Ireland (NOMAD and Broker)

    Chris Fielding / Darshan Patel

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBBQBKDBBD

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings